For more information or confidential assistance
800-306-3180
se habla español

Oregon Mother Claims Zofran Caused Baby’s Cleft Palate

pregnant woman wearing white in profile
An increasing number of lawsuits involving Zofran-related birth defects have been filed across the nation. One of the latest claims was brought by an Oregon mother who argues that her child’s cleft palate and laryngeal cleft are a direct result of the anti-nausea drug she took while pregnant. GlaxoSmithKline LLC... Read more »

Study Suggests Risperdal Boosts Childhood Diabetes Risk

A report recently published in the renowned JAMA Psychiatry journal indicates that children who are given antipsychotic drugs including Risperdal, Seroquel and Zyprexa may experience a greater likelihood of developing diabetes than those who have not been prescribed those medications to treat their mental health conditions. The study, conducted by doctors from... Read more »

Testosterone Claim Involving Testim Joins MDL 2545

Byetta pancreatic cancer patient
An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation in the Northern District of Illinois. According to his short form complaint, the man was prescribed and began taking Testim in June 2010. In... Read more »

Couple Files Mesothelioma Lawsuit Against Colgate, Pfizer

Courthouse
A Wisconsin couple has filed a lawsuit against the Colgate-Palmolive Company, Pfizer and a number of affiliates, claiming asbestos in some of the companies’ talc products caused the husband to develop mesothelioma. From approximately 1967 through the 1970’s, Steven P. Schultz’s mother used the asbestos-containing Cashmere Bouquet Talcum Powder products... Read more »

Government Office Expresses Concern With FDA Drug Oversight

The federal Food and Drug Administration (FDA) is tasked with the tremendous responsibility of keeping American consumers safe from dangerous drugs and medical devices. Accordingly, the agency has not only implemented strict pre-market testing and screening measures for new products, but it is required to monitor the products after their... Read more »

Report Highlights Risks of Newer Diabetes Drugs

Metabolic acidosis is a risk associated with Invokana that was recently highlighted in a report by the Institute for Safe Medical Practices (ISMP). Invokana is one of the drugs recently touted for its ability to manage type 2 diabetes, but potential side effects have raised concerns and led to a... Read more »

GSK Files Motion to Dismiss Zofran Birth Defect Claims

Attorneys for GlaxoSmithKline (GSK) have petitioned that Zofran lawsuits involving birth defects filed against the company be dismissed by the federal judge overseeing litigation. The move comes relatively early in the course of a multidistrict litigation (MDL 2657) set up to process the increasing number of lawsuits filed over birth defects... Read more »

Invokana Lawsuit Filed in Alabama District Court

The drug Invokana belongs to a class of Type II diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and is referred to generically as canagliflozin. This class of drugs, which also includes well-known brands like Farxiga, Xigdua XR, Jardiance and Glyxambi, was once highly-touted as an innovative alternative for Type II... Read more »